Purinergic signaling, dyslipidemia and inflammatory disease.

about

A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes P2X receptors regulate adenosine diphosphate release from hepatic cells.

P2860

Q28083355-F9B5373E-2EE5-47EA-B010-E718F49D42C4 Q38971994-92A1862E-1C9E-48DD-BE9F-4DD5B623AB14

P2860

Purinergic signaling, dyslipidemia and inflammatory disease.

Item

http://www.wikidata.org/entity/Q38055327

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Purinergic signaling, dyslipidemia and inflammatory disease.

@en

type

Item

label

Purinergic signaling, dyslipidemia and inflammatory disease.

@en

prefLabel

Purinergic signaling, dyslipidemia and inflammatory disease.

@en

P1476

Purinergic signaling, dyslipidemia and inflammatory disease.

@en

P2093

Cynthia Chatterjee

http://www.w3.org/2001/XMLSchema#string

Daniel L Sparks

http://www.w3.org/2001/XMLSchema#string

P2860

Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

P2X receptors as cell-surface ATP sensors in health and disease

Autophagy and the integrated stress response

Mechanisms of ATP release and signalling in the blood vessel wall.

P2 receptor agonists stimulate insulin release from human pancreatic islets.

Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy.

Internalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3.

Extracellular ATP in the immune system: more than just a "danger signal".

Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterol

P304

1333-1339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000343322

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232699295

http://www.w3.org/2001/XMLSchema#string

P698

23095900

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias

Purinergic signaling, dyslipidemia and inflammatory disease.

about

P2860

P2860

Purinergic signaling, dyslipidemia and inflammatory disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921